Navigation Links
Arena Pharmaceuticals to Present at the Piper Jaffray 23rd Annual Health Care Conference
Date:11/23/2011

tion of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, the following: the timing of regulatory review and approval is uncertain; regulatory agencies may interpret or weigh the importance of data differently and reach different conclusions than Arena or others, request additional information, have additional recommendations or change their guidance or requirements before or after approval; the risk that data and other information related to Arena's research and development programs may not meet safety or efficacy requirements or otherwise be sufficient for regulatory approval; Arena's response to the complete response letter for the lorcaserin new drug application or submission of a marketing authorization application for regulatory approval of lorcaserin may not be submitted when anticipated, if at all; unexpected or unfavorable new data; risks related to commercializing new products; Arena's ability to obtain and defend its patents; the timing, success and cost of Arena's research and development programs; results of clinical trials and other studies are subject to different interpretations and may not be predictive of future results; clinical trials and other studies may not proceed at the time or in the manner expected or at all; Arena's ability to obtain adequate funds; risks related to relying on collaborative agreements; the timing and receipt of payments and fees, if any, from collaborators; and satisfactory resolution of pending and any future litigation or other disagreements with others. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena'
'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Michael DeMarco (42) erinnert sich ... Februar 2014 zugetragen hat. Seine Tochter Aly Demarco (13) ... Video - http://youtu.be/5cVoMCe0uiE „Man ... Training zu machen", erzählt Michael DeMarco . „Meine ... begeisterte Anhänger der CrossFit-Trainingsmethode. Ich war auf dem Fahrrad, ...
(Date:11/21/2014)... BEVERLY HILLS, Calif. , Nov. 20, 2014 ... Ken Eaton , the election of Anthony J. ... as President. Effective November 19, 2014, ... and member of the Board of Directors of Oxis International, ... J. Cataldo has been named Chief Executive Officer of ...
(Date:11/21/2014)... 21, 2014  Lexicon Pharmaceuticals, Inc. (Nasdaq: ... offering of $80,000,000 aggregate principal amount of 5.25% Convertible ... private offering within the United States ... buyers pursuant to Rule 144A under the Securities Act ... also granted the initial purchasers an option to purchase ...
Breaking Medicine Technology:Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3Lexicon Announces Pricing Of Convertible Senior Notes Offering 2Lexicon Announces Pricing Of Convertible Senior Notes Offering 3
(Date:11/22/2014)... 2014 (HealthDay News) -- A clinical trial of hydroxyurea ... halted a year early because the results show it ... disease and reduce the risk of stroke. The ... medical centers in the United States and Canada, was ... and Blood Institute (NHLBI). Researchers compared monthly blood ...
(Date:11/22/2014)... FRIDAY, Nov. 21, 2014 (HealthDay News) -- Those air-blown ... germs than conventional paper towels, a new study suggests. ... on the hands of volunteers in order to simulate ... dryers, high-powered "jet-air" dryers or paper towels to dry ... and found higher amounts of germs around both types ...
(Date:11/22/2014)... widely used heart drug digoxin is associated with increased ... the heart rhythm disorder atrial fibrillation but no evidence ... fibrillation is a common form of irregular heartbeat that ... stroke among older Americans. Digoxin has been used for ... the authors of the new study said, and many ...
(Date:11/21/2014)... CRN International, the radio marketing and ... professional to its award-winning team. , Leslie Heinemann, most ... and sales experience to CRN. She will be based ... Director of Strategy and Development, reporting to CRN Managing ... will handle a wide range of territories and market ...
(Date:11/21/2014)... FL (PRWEB) November 21, 2014 Body Well ... announced that it accepts Spafinder massage gift cards ... in room hotel massage in all service areas including throughout ... don't have to go to the spa at all to ... and Founder of Body Well. "We may not be able ...
Breaking Medicine News(10 mins):Health News:Sickle Cell Anemia Treatment So Successful in Kids That Trial Is Halted 2Health News:Restroom Hand Dryers Spread More Germs Than Paper Towels, Study Finds 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 3Health News:Radio Industry Veteran Joins CRN International’s Sales Organization in Detroit 2Health News:Body Well Mobile Massage Announces Acceptance of Spafinder Gift Cards for In Home Massage, Hotel Massage for Travelers 2
... America,s Health (TFAH) released a new report today ... change plan that includes a public health response. This includes ... natural disasters, pollution, and infectious diseases as temperatures and sea ... Climate Change and the Public,s Health report examines U.S. ...
... years of experience in cancer research and patient care, ... released today the most comprehensive, risk-based screening guidelines publicly ... The new recommendations represent the first wave ... the effectiveness of efforts to prevent and detect cancer ...
... MD, a principal investigator at Los Angeles Biomedical Research ... one of India,s highest honors, the "Hind Rattan Award," ... presents annually for "outstanding services, achievements and contributions" by ... Welfare Society will present the honor to Dr. Mehrotra ...
... SCOTTSDALE, Ariz. A new Mayo Clinic study suggests that ... uses wireless technology in diagnosing intestinal disease, is safe ... as cell phones, have been shown to interfere with ... has led medical experts to speculate that capsule endoscopy ...
... world,s fastest supercomputer, Roadrunner, at Los Alamos National ... accelerated petascale computer modeling and simulations of a ... Roadrunner system is now beginning its transition to ... reliability of the U.S. nuclear deterrent. ...
... Park live to be nearly six years old, their ability to ... a study led by Dan MacNulty and recently published online by ... December print issue. The finding challenges a long-held ... It now appears that like human athletes, they are only at ...
Cached Medicine News:Health News:Only Five States Have Plans to Address the Health Impact of Climate Change, New Report Finds 2Health News:Only Five States Have Plans to Address the Health Impact of Climate Change, New Report Finds 3Health News:Only Five States Have Plans to Address the Health Impact of Climate Change, New Report Finds 4Health News:M. D. Anderson redefines screening guidelines for breast, cervical and colorectal cancers 2Health News:M. D. Anderson redefines screening guidelines for breast, cervical and colorectal cancers 3Health News:M. D. Anderson redefines screening guidelines for breast, cervical and colorectal cancers 4Health News:LA BioMed researcher to be honored 2Health News:Mayo Clinic study shows people with heart devices can 'digest' advanced diagnostic technology safely 2Health News:Mayo Clinic study shows people with heart devices can 'digest' advanced diagnostic technology safely 3Health News:Science at the petascale: Roadrunner results unveiled 2Health News:Science at the petascale: Roadrunner results unveiled 3Health News:Wolves lose their predatory edge in mid-life, new U of Minnesota study shows 2
Cholesterol/HDL Standard 50 mg/dl....
For the quantitative determination of High Density Lipoprotein in serum. Available in liquid type. Polyethylene glycol (6000) precipitating reagent. Linearity: 200 mg/dl....
... Intended for the ... in plasma. Two vials, ... Enzymatic, alphaketoglutarate. Uses NADPH ... other plasma compounds. Reaction: ...
... The ProteomeLab XL-A/XL-I functions over a ... strength and pH, delivering more thorough ... operating methodology measures the relative change ... providing an efficient way to measure ...
Medicine Products: